ABSTRACT
T raumatic vascular injuries of the cervical vertebral and carotid arteries, including vascular dissection and pseudoaneurysm formation, can be the result of blunt or penetrating trauma. These injuries often occur in the setting of rotational, hyperextension, or hyperflexion injury and are frequently related to motor vehicle collisions. Blunt cervical vascular injury is associated with a 12.2% risk of acute cerebral ischemia 1 and is the cause of stroke in approximately 15% of patients 16 -45 years of age presenting with acute cerebral ischemia. 2 Furthermore, patients with accompanying injuries, such as acute cervical spine fracture, basilar skull fracture, major thoracic injury, and mandibular fracture are at risk of vascular injury. 1, 3 The diagnosis of cervical vascular injury in patients with trauma or suspected cervical vascular injury is most commonly confirmed with CTA (Fig 1) , MR imaging, duplex sonography, and/or conventional angiography. A recent evaluation of CTA with 16-section CT scanners demonstrated a 97.7% sensitivity and 100% specificity compared with the criterion standard of conventional angiography. 4 Earlier studies suggested that BCVI involving either the carotid or vertebral arteries was present in 0.1% of patients hospitalized for trauma 5 ; however, recent data based on more aggressive screening protocols demonstrate a higher prevalence of BCVI at 1.2%-1.6% of all patients with trauma 1, 6, 7 and in 2.7% of patients with severe multisystem trauma. 8 Further subdivided, carotid injuries were identified in 0.32% of all patients with blunt trauma, 9 and vertebral injures were identified in 0.53% of all patients with blunt trauma. 10 Penetrating injuries are less commonly seen.
Carotid and vertebral artery injuries may occur "spontaneously" or may be iatrogenic. The pathogenesis of spontaneous injuries may relate to underlying structural or collagen-vascular defects of the arterial wall, including Ehlers-Danlos syndrome, Marfan syndrome, autosomal dominant polycystic kidney disease, osteogenesis imperfecta type I, or other nonspecific abnormalities such as fibromuscular dysplasia and cystic medial necrosis. 11 Additional factors, such as chiropractic manipulation and unrecognized or remote trauma, may also be significant contributing factors in spontaneous cervical vascular injury. The average annual incidence of these spontaneous injuries has been reported to range between 2.6 and 2.9 per 100,000. 12 Although risk factors for BCVI have been analyzed to prescribe criteria for screening, 13 data and recommendations regarding treatment options and outcomes for patients with vascular injuries are more limited. Asymptomatic patients with low-grade injuries are typically treated conservatively with medical management and imaging follow-up. Studies have shown a decrease in neurologic sequelae with the use of antithrombotic or antiplatelet agents in these patients, with no significant difference between the 2 agents. 14, 15 Unfortunately, contraindications to anticoagulants and antiplatelet agents in patients with multisystem injury, including the presence of intracranial hemorrhage, often complicate the treatment paradigm within the trauma population. Few prospective trials have been performed to evaluate the safety and efficacy of endovascular therapy in patients with acute traumatic carotid artery injury. The use of cervical and intracranial vascular stents and coils in the treatment of TCAI has been described; however, only a few small retrospectives series have been published. The largest of these reviews describes encouraging results for carotid artery stents placed in 29 patients. 16 In 2005, however, Cothren et al 17 showed a 21% complication and 45% occlusion rate following carotid stent placement in patients with grade 3 injuries, while those patients treated with anticoagulation alone demonstrated only a 5% occlusion rate. Although these data are discouraging, the high occlusion rate in the treatment group may be attributable to the fact that all patients who had complications within the stent arm of the study received pre-and posttreatment with only anticoagulation agents rather than antiplatelet therapy. 
MATERIALS AND METHODS

Patient Selection
Following approval by the institutional review board, we retrospectively reviewed the records and imaging studies of patients with trauma who had undergone endovascular extracranial internal carotid artery repair for acute dissection with or without pseudoaneurysm formation at the University of Maryland Medical Center between 1999 and 2009. (Authors were previously affiliated with the University of Maryland.) Nontraumatic dissections were excluded. Fifty-three endovascular interventions were performed in 47 patients.
Evaluation
Initial evaluation for TCAI was performed with contrast-enhanced CT or conventional angiography. Injuries were evaluated with regard to patient age, sex, injury grade, injury location, complications, initial treatment results, and outcomes. A modified Biffl classification was created and used to grade injuries. 18 In our modification (Table 1) , we included both blunt and penetrating injuries. Additionally, grade 2 and 3 injuries were further subdivided into 2a or 3a (non-flow-limiting when Ͻ70% luminal narrowing was present) and 2b or 3b (flow-limiting when Ͼ70% luminal narrowing was present). The degree of luminal narrowing was determined at the time of angiography by experienced neurointerventionalists on 2D cerebral angiographic images. The location of the vascular injury was divided into proximal ICA (Ͼ3 cm below the skull base) and distal ICA (Ͻ3 cm from the skull base).
The criteria used for patients who underwent endovascular stent treatment included grade 2b and 3b injuries, progressive pseudoaneurysm enlargement, or marked intimal irregularity associated with grade 2a injury.
Procedure
All endovascular procedures were performed in the course of routine clinical practice by experienced neurointerventional radiologists. Written informed consent was obtained for all patients, and either moderate conscious sedation or general endotracheal anesthesia was administered.
All patients received either an emergent loading bolus of 300 or 600 mg of clopidogrel with or without 650 mg of acetylsalicylic acid or were pretreated for 5 days with ASA, 325 mg, and clopidogrel, 75 mg. Transfemoral arterial access was used in all cases. Self-expanding stents and/or detachable platinum coils were deployed under fluoroscopic, angiographic, and roadmap guidance. Dual antiplatelet therapy (ASA, 325 mg, and clopidogrel, 75 mg daily) was administered for a minimum of 12 weeks following stent and/or coil placement.
Outcome and Follow-Up
Initial treatment results and outcomes were classified into 4 categories: complete restoration of normal vessel lumen diameter ( Fig  2) ; clinically acceptable results with mild residual pseudoaneu- rysm filling or luminal narrowing Ͻ30%; residual or recurrent narrowing Ͼ30%; and an aborted procedure or inability to deploy a stent or coils. Follow-up examinations were predominantly performed with CTA, MRA, and conventional catheter angiograms. Duplex sonography was not used due to the predominance of distal injuries within our study group.
RESULTS
Patient Characteristics
We identified 47 patients (32 men, 15 women) who underwent endovascular treatment for TCAI. Six patients had bilateral injures; thus, 53 injuries were identified. Of these 6 patients, 3 underwent bilateral endovascular treatment for a total of 50 endovascular treatments. The remaining 3 patients with bilateral injuries underwent unilateral endovascular treatment and were followed with sequential imaging. Three patients required repeat treatment, resulting in 53 endovascular interventions.
The average age at the time of treatment was 34 years and ranged from 17 to 71 years. The etiology of injury included 47 (88.7%) blunt injuries and 6 (11.3%) penetrating injuries. The number of treated vessels within each grade was as follows: grade 2a (n ϭ 5), grade 2b (n ϭ 2), grade 3a (n ϭ 27), and grade 3b (n ϭ 16). A single grade 2a and 2 grade 3a injuries were left untreated and were stable on multiple follow-up examinations. Fifteen (28.3%) injuries were in the proximal internal carotid artery, and 38 (71.7%) injuries were in the distal cervical internal carotid artery.
Twenty-one patients initially treated with medical management required endovascular treatment due to progressive luminal narrowing or pseudoaneurysm development/enlargement. Eighteen (87.5%) of these injuries were initially classified as grade 3a injures, and 3 (14.3%) were initially grade 2a injuries. Injury progression necessitating treatment was identified, on average, within 5 weeks of the initial injury and at a maximum of 10 weeks following the initial injury. These results are summarized in Table 2 .
Treatment
Forty-four injuries were initially treated with stents alone, 4 initially required both stent and coil treatment, and 2 were treated with coils alone. Two patients initially treated with stents and 1 patient initially treated with stents and coils required stent and/or coil retreatment. Of the injuries treated with stent placement, 31 (64.6%) were treated with a single stent and 17 (35.4%) required multiple stents. Initial treatment resulted in complete restoration of normal vessel lumen diameter in 25 treated vessels (50%) and good-toacceptable restoration in 25 (50%) vessels. No patients were left with Ͼ30% residual narrowing after initial treatment. Most grade 3 injuries demonstrated minimal residual pseudoaneurysm filling with acceptable restoration of lumen caliber on immediate posttreatment angiograms.
Stent placement was aborted in a single patient with grade 3a injury due to underlying fibromuscular dysplasia. The patient initially presented with bilateral grade 2a carotid injuries; however, follow-up CTA at 1 month demonstrated development of a unilateral pseudoaneurysm, and unilateral endovascular stent placement was successfully performed. Catheter angiography at 1 year demonstrated patency of the carotid stent and an unchanged dissection flap of the contralateral carotid artery with interval development of a very small pseudoaneurysm. Proximal irregularity of the vessel was consistent with fibromuscular dysplasia. Due to the overall stability of the lesion at 1 year and the presence of underlying dysplastic changes, stent placement was aborted to mitigate the risk of worsening dissection. Follow-up examination at 3 years demonstrated a stable appearance of the bilateral internal carotid arteries.
The 2 patients in whom endovascular coils were used without placement of an endovascular stent both suffered from blunt traumatic injuries. The patients were 23 and 24 years of age and the use of endovascular stents was avoided due to their age and to mitigate the need for prolonged antithrombotic therapy. The first patient presented with a grade 2a injury, and a follow-up CT performed 2 days after the initial injury demonstrated development of a small distal cervical carotid pseudoaneurysm without flowlimiting stenosis (grade 3a). A conventional angiogram performed 2 weeks later demonstrated significant interval enlargement of the pseudoaneurysm as well as 80% narrowing of the internal carotid artery (grade 3b) (Fig 3A, -B) . Nine platinum coils were placed into the pseudoaneurysm sac, and only minimal residual filling was seen on the postprocedural angiogram on the day of treatment (Fig 3C) . Follow-up MRA at 6 weeks demonstrated improvement in vessel caliber and no pseudoaneurysm filling (Fig 3D) . The second patient presented with a grade 3a injury ( Fig 4A) ; multiple follow-up examinations for up to 3 months showed progressive pseudoaneurysm enlargement (Fig  4B-D) . Endovascular treatment with balloon-assisted placement of 9 platinum coils was performed, and only minimal residual filling was seen on the postprocedural angiogram (Fig 4E) . Follow-up MRA at 5.5 months after treatment demonstrated no residual pseudoaneurysm filling (Fig 4F) . Neither patient had any procedural or postprocedural complication. These results are summarized in Table 3 .
Follow-Up and Outcomes
Thirty-nine patients (83.0%) had either CT or MR imaging follow-up; 9 patients (19%) were followed with both modalities. Fourteen (29.8%) of these patients also underwent conventional angiography at follow-up. A single patient (2.1%) had follow-up with only conventional angiography. Seven patients (14.9%) were lost to follow-up, and no imaging examinations were performed following treatment. The initial imaging or angiographic follow-up interval ranged from 1 day to 6 months. The total length of follow-up ranged from 4 days to 7 years and included 64 CT/CTA examinations, 17 MR imaging/MRA examinations, and 23 catheter angiograms. On the basis of the results of follow-up studies, 3 additional interventions were performed. The average interval from initial procedure to this retreatment was 3 weeks. Both stents and coils were used successfully to achieve complete occlusion in all 3 cases. These results are summarized in Table 3 .
Complications
Three of 47 patients (6.4%) had transient complications related to endovascular treatment. Temporary weakness was noted in 2 patients, and transient vision loss occurred in another. The complications resolved without surgical or further endovascular intervention in all 3 patients.
Stent-related complications were observed in 2 (4%) of 50 procedures. Complete stent occlusion occurred in a single patient (2.0%). This patient had severe vasospasm at the time of the in- tervention. Resolution of spasm following immediate intra-arterial therapy and patency of the stent were documented by angiography at the termination of the case. However, follow-up CTA on postprocedural day 8 demonstrated complete stent occlusion. Collateral intracranial flow through the circle of Willis was present, and follow-up MR imaging on postprocedure day 14 demonstrated no evidence of infarction. The patient remains clinically asymptomatic from the occlusion.
A single patient (2.1%) initially treated for a grade 2b dissection of the proximal right internal carotid artery demonstrated a new pseudoaneurysm and some luminal narrowing on follow-up CTA performed 1 week following stent placement (Fig 5A, -B) . A catheter angiogram confirmed these findings, and luminal restoration with near-complete occlusion of the pseudoaneurysm sac was achieved with coil embolization and placement of an additional stent (Fig 5C) .
Two of the treated patients (4.3%) required repeat intervention for unhealed initial injuries. The first patient underwent stent placement for a lengthy grade 3a dissection and pseudoaneurysm with 50% narrowing of the mid-to-distal left internal carotid artery secondary to a motor vehicle collision. Follow-up angiography 1 week later demonstrated persistent filling of the pseudoaneurysm sac. Complete occlusion was achieved with coil embolization and placement of an additional stent. The second patient had a focal grade 2a dissection of the mid-to-distal left internal carotid artery and was initially treated conservatively. Follow-up CTA at 2 months demonstrated progression of the dissection with formation of a new 3-mm pseudoaneurysm, and No groin-related complications were identified. There were no deaths or permanent morbidity relating to endovascular carotid artery repair.
DISCUSSION
Although risk factors and screening recommendations have been suggested, 4 the appropriate choice of treatment for TCAI remains debated. Antithrombotic and antiplatelet agents are advocated in patients without contraindications and have been shown to decrease the incidence of neurologic sequelae and mortality related to carotid injury when compared with no treatment. 14, 19, 20 In patients that underwent surgical treatment, surgical repair resulted in a lower mortality rate (7.8%) when compared to surgical ligation (50%). 21 However, patients with severe neurologic deficits have not demonstrated a significant improvement in outcome with either surgical treatment or anticoagulation therapy. 22 In patients with only cervical vascular injury, treatment typically consists of a choice between antithrombotic therapy and endovascular repair. However, endovascular repair with stents also requires pre-and posttreatment antiplatelet therapy to avoid embolic complications or stent occlusion. This often results in a frustrating clinical conundrum because many patients are referred for endovascular repair specifically due to contraindications to antithrombotic therapy such as severe intracranial injury, multisystem trauma, or penetrating injuries. Unless faced with an immediately life-threatening injury, our practice has been to avoid placement of stents in patients who have not or cannot receive appropriate pre-and postprocedural antiplatelet therapy.
Biffl et al 23 in 2002 advocated a 7-to 10-day angiographic follow-up on the basis of their observation that most grade 1 or 2 injuries demonstrated either complete healing or progression within that time period. In our practice, we typically recommend CTA follow-up within 3-5 days for patients treated with antiplatelet medications alone. Additional follow-up CTA was acquired 1 week later and at increasing intervals until stability of the injury was documented or a decision to intervene was made.
Only limited prospective data are available regarding the safety and efficacy of carotid artery stent placement in the setting of trauma, and most published results are from small case review series. A single prospective study by Cothren et al 17 showed discouraging results with a high rate of stent occlusion; however, we believe that the lack of antiplatelet therapy in patients with complications may have played a role in those poor outcomes. Published retrospective studies, on the other hand, have shown encouraging results. A series of 6 patients treated with endo- vascular stent placement for enlarging pseudoaneurysms reported by Duke et al 24 in 1997 showed complete healing in all patients, suggesting that endovascular stents were a safe and effective alternative to surgery. A more recent and larger series reported 29 procedures with only 2 long-term complications; once again, both patients who had complications had not received antiplatelet medications. 16 In a small study of 7 patients with a 3.5-year follow-up, Liu et al 25 reported no postprocedural complications and a single asymptomatic occlusion at 3 months. A case review series of 14 patients by Coldwell et al 26 in 2000 demonstrated no procedural complications and complete healing of all treated vessels at 4-month follow-up.
Our experience with cervical vascular injury at a large trauma center has been substantial. To our knowledge, this report represents the largest published case series review of endovascular treatment for TCAI. In our study population, blunt injuries were 9 times more frequent than penetrating injuries, and men outnumbered women by Ͼ2 to 1, reaffirming that men are at higher risk than women for traumatic carotid injury. There were transient postprocedural complications in 3 of 50 procedures (6.0%). A single stent placement procedure (2.0%) resulted in delayed asymptomatic vessel occlusion, and follow-up imaging at 2 months and clinical follow-up at 1 year demonstrated no evidence of cerebral infarction. One patient (2%) developed a new pseudoaneurysm and was successfully treated endovascularly. Although a small amount of residual filling of the pseudoaneurysm sac was frequently seen after initial treatment, follow-up studies showed complete occlusion of the sac in nearly all of our patients. Only 2 of the 47 treated patients (4.3%) required additional endovascular treatment for residual pseudoaneurysm filling, thus demonstrating the durability of successful initial endovascular repair. Overall, various grades of injury were treated successfully, with minimal complications and no mortality related to this repair.
As with most retrospective reviews, there are limitations to our study. Specifically, there was significant variability in the time interval at which follow-up examinations were obtained, and no imaging follow-up was performed in 7 patients. In addition, there was significant variability in the technique and imaging protocols used to follow either treated or untreated injuries.
The 2 identified complications directly related to endovascular therapy occurred within the first 2 weeks after treatment. In patients treated with endovascular stents, only 2 patients had progressive pseudoaneurysm enlargement necessitating intervention. Both of these patients were identified within 5 weeks of the initial treatment and were successfully treated with endovascular pseudoaneurysm coil occlusion. In patients with long-term follow-up, there were no significant late-occurring adverse effects related to treatment. Taken together, these findings indicate a need for close surveillance in the perioperative period and extending to 60 days. Most of our stented patients are now maintained on dual oral antiplatelet agents (ASA, 325 mg, and clopidogrel bisulfate, 75 mg daily) for 12 weeks, at which time a follow-up imaging study is performed. If follow-up imaging demonstrates a stable or improving appearance, patients are then maintained on ASA, 81 mg, daily for life. The mean age of 34 years in our study population is distinctly different from the population typically undergoing stent placement for atherosclerotic carotid stenosis, and concerns about life-long antiplatelet therapy should guide treatment decisions in individual cases. Potential morbidity related to life-long oral antiplatelet therapy and the risk of noncompliance for many years are concerning. Taking this into consideration, 2 young patients (23 and 24 years of age) with grade 3 injuries were treated with coil placement alone to avoid the need for life-long antiplatelet therapy. Both patients showed no residual pseudoaneurysm and had no postprocedural complications. Furthermore, follow-up imaging demonstrated significant healing of the carotid artery, with improvement in vessel caliber in both cases. We suspect that this improvement in caliber is due to diminished perivascular inflammation and related mass effect on the parent artery following effective endovascular treatment. Although the optimal treatment for extracranial carotid artery dissection with or without pseudoaneurysm remains controversial, our study adds to the previously published data demonstrating that endovascular therapy is a safe and effective method of restoring luminal caliber in traumatic carotid artery injuries. Continued investigation is required to better stratify patients into groups benefiting most from medical management and those in whom endovascular repair is necessary. With the addition of our modification of the Biffl scale to account for high-grade stenosis, our study demonstrated a subset of patients in whom either intervention or close interval follow-up may be required. Specifically, of the 21 patients initially treated with medical management who required endovascular treatment due to injury progression, 18 (85.7%) had grade 3a injures and 3 (14.3%) had grade 2a injuries. On average, progression of injury grade necessitating treatment was identified within 5 weeks of the initial injury. We, therefore, suggest that imaging follow-up of all carotid injuries, especially those deemed to be grades 3a and 2a injuries, should be performed within the critical period of the first 45 days after injury.
CONCLUSIONS
We reviewed 50 extracranial internal carotid injuries that were successfully treated with endovascular therapy consisting of stent placement or stent-assisted coil placement. Endovascular therapy is a safe and effective option for rapidly restoring luminal caliber and eliminating flow within pseudoaneurysms related to traumatic injuries of the cervical internal carotid artery. Both flowlimiting and non-flow-limiting dissections and pseudoaneurysm formation demonstrate durable healing after treatment. Imaging follow-up of all cervicocerebral vascular injuries is especially important within the first 45 days, a critical interval during which most lesions demonstrate healing or progression. Noninvasive imaging such as CTA, MR imaging, and MRA was useful for initial diagnosis and follow-up. Complications were rare and did not result in permanent morbidity or mortality. We attribute the low rate of complications to our routine use of oral antiplatelet medications before and following endovascular treatment.
